A team at Scripps Research says it has discovered hundreds of proteins that are constantly transported throughout the healthy brain in small membrane-enclosed sacs, revealing a new form of communication between brain cells. Their study “Proteomic screen reveals diverse protein transport between connected neurons in the visual system,” published in Cell Reports, may help scientists better understand neurological diseases, including Alzheimer’s and autism.
“This is an entirely new way that cells in the brain can communicate with one another that has never before been integrated into how we think about health and disease,” says Hollis Cline, PhD, Hahn professor of Neuroscience at Scripps Research. “It opens up a lot of exciting avenues of research.”
To send signals throughout the brain, neurons typically communicate using neurotransmitters, which move from one cell to an adjacent one. Hormones also circulate through the brain, affecting the growth of brain cells and helping forge new connections between neurons.
Previously, researchers had suspected that a small number of proteins may move more independently around the brain in isolated instances. For example, scientists studying Alzheimer’s disease found that synuclein and tau, which are two proteins associated with neurodegeneration, could move between cells in the brains of animals affected by Alzheimer’s. But they were not sure if this was related to the disease itself.
Other teams have provided evidence that a protein originating from one cell can later be found in another; they could not eliminate the possibility, however, that the protein was disassembled into its amino acid building blocks and later reassembled in the destination cell.
In the new work, Cline and her colleagues used a method of labeling proteins that ensured they only tracked proteins that stay intact. The tag, a biotin molecule, cannot be reintegrated into new proteins if the proteins are disassembled. The research team introduced the tag into retinal ganglion cells in the eyes of rats. Eleven days later, they examined cells from the visual cortex, an area of the brain responsible for processing vision and physically distant from the retinal ganglion cells.
Cline’s team next isolated any protein in the visual cortex that was tagged with biotin. They found more than 200 proteins and collaborated with Scripps Research professor John Yates III, PhD, to identify each protein using mass spectrometry.
“Intercellular transfer of toxic proteins between neurons is thought to contribute to neurodegenerative disease, but whether direct interneuronal protein transfer occurs in the healthy brain is not clear. To assess the prevalence and identity of transferred proteins and the cellular specificity of transfer, we biotinylated retinal ganglion cell proteins in vivo and examined biotinylated proteins transported through the rodent visual circuit using microscopy, biochemistry, and mass spectrometry,” write the investigators.
“Electron microscopy demonstrated preferential transfer of biotinylated proteins from retinogeniculate inputs to excitatory lateral geniculate nucleus (LGN) neurons compared with GABAergic neurons. An unbiased mass spectrometry-based screen identified ∼200 transneuronally transported proteins (TNTPs) isolated from the visual cortex. The majority of TNTPs are present in neuronal exosomes, and virally expressed TNTPs, including tau and β-synuclein, were detected in isolated exosomes and postsynaptic neurons.
“Our data demonstrate transfer of diverse endogenous proteins between neurons in the healthy intact brain and suggest that TNTP transport may be mediated by exosomes.”
Limitations of previous methods
Previous methods didn’t allow researchers to identify specific proteins being transported or watch the process at an ultrastructural level, according to Lucio Schiapparelli, PhD, first author of the new paper and a former staff scientist at Scripps Research now at Duke University. “So,” he explains, “using this new combination of protein tagging and identification strategies allowed us to make headway in really understanding what was happening with these proteins.”
The proteins identified included many with known functions in the brain, including the tau and synuclein seen moving between cells in Alzheimer’s disease.
“This is a confirmation that in the healthy brain, tau and synuclein, and their movement around the brain, is normal,” says Cline. “But with Alzheimer’s disease it’s a toxic form of the protein that is transported between neurons.”
The researchers also used a different set of protein tags to show that, in most cases, these proteins were being transported between cells inside exosomes. This discovery can help pave the way for other researchers who want to follow protein movements in other areas of the brain, as well as compare interneuronal protein transport in healthy versus diseased brains. While the new work was carried out in the visual system, Cline says there’s no reason not to think the results are further reaching.
“There are likely proteins being shuttled around in this mechanism all throughout the brain,” she says. “What I really hope is that this spurs new interest in exploring the roles of intercellular communication that we had not known about until now.”